title: [Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome].
authors.forename: V A
authors.initials: VA
authors.lastname: Stupin
authors.forename: A I
authors.initials: AI
authors.lastname: Prividentsev
authors.forename: S V
authors.initials: SV
authors.lastname: Goriunov
authors.forename: S V
authors.initials: SV
authors.lastname: Zhilina
authors.forename: V I
authors.initials: VI
authors.lastname: Vasin
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification; D003131:Combined Modality Therapy; D017719:Diabetic Foot / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology / Q000601:surgery; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D012720:Severity of Illness Index; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013514:Surgical Procedures, Operative / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D000077266:Moxifloxacin